Literature DB >> 15660330

Hemodynamics of hyperuricemia.

Laura G Sánchez-Lozada1, Edilia Tapia, Bernardo Rodríguez-Iturbe, Richard J Johnson, Jaime Herrera-Acosta.   

Abstract

Prolonged hyperuricemia is associated with the development of hypertension, renal arteriolosclerosis, glomerulosclerosis, and tubulointerstitial injury. It confers a greater risk than proteinuria for developing chronic renal disease and is associated with the development of hypertension. Mild chronic hyperuricemia without intrarenal crystal deposition was induced in rats by inhibiting uricase with oxonic acid. Hyperuricemic rats developed hypertension, afferent arteriolar thickening, and mild renal interstitial fibrosis. Additionally, hyperuricemia accelerated renal damage and vascular disease in rats undergoing renal ablation. To better understand the role of hyperuricemia in the kidney, micropuncture studies were performed. Hyperuricemia resulted in renal cortical vasoconstriction (single nephron glomerular filtration rate (SNGFR) 35%, P < .05) and glomerular hypertension (P < .05). The possibility that hyperuricemia could modify renal hemodynamic disturbances during progression of renal disease was tested in rats with 5/6 nephrectomy. Hyperuricemia accentuated the renal vascular damage and caused cortical vasoconstriction (SNGFR 40%, P < .05) and persistent glomerular hypertension. In conclusion, hyperuricemia impairs the autoregulatory response of preglomerular vessels, resulting in glomerular hypertension. Lumen obliteration induced by vascular wall thickening results in severe vasoconstriction. The resulting ischemia is a potent stimulus that induces tubulointerstitial inflammation and fibrosis as well as arterial hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15660330     DOI: 10.1016/j.semnephrol.2004.09.004

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  10 in total

1.  The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic.

Authors:  Mark S Segal; Titte R Srinivas; Rajesh Mohandas; Jonathan J Shuster; Xuerong Wen; Elaine Whidden; JogiRaju Tantravahi; Richard J Johnson
Journal:  J Am Soc Hypertens       Date:  2015-05-22

2.  Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease.

Authors:  Baris Afsar; Rengin Elsurer; Adrian Covic; Richard J Johnson; Mehmet Kanbay
Journal:  Am J Nephrol       Date:  2011-06-10       Impact factor: 3.754

3.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

4.  Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study.

Authors:  Gim Gee Teng; Li-Wei Ang; Kenneth G Saag; Mimi C Yu; Jian-Min Yuan; Woon-Puay Koh
Journal:  Ann Rheum Dis       Date:  2011-12-15       Impact factor: 19.103

5.  Serum uric acid and chronic kidney disease: the role of hypertension.

Authors:  Sanaz Sedaghat; Ewout J Hoorn; Frank J A van Rooij; Albert Hofman; Oscar H Franco; Jacqueline C M Witteman; Abbas Dehghan
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

Review 6.  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.

Authors:  Stefanos Roumeliotis; Athanasios Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

7.  Is Water-Only Fasting Safe?

Authors:  Ewa Ogłodek; Wiesław Pilis Prof
Journal:  Glob Adv Health Med       Date:  2021-08-05

Review 8.  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.

Authors:  Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Semin Nephrol       Date:  2020-11       Impact factor: 5.299

9.  Allopurinol for prevention of progression of kidney disease with hyperuricemia.

Authors:  B H Santhosh Pai; G Swarnalatha; R Ram; K V Dakshinamurty
Journal:  Indian J Nephrol       Date:  2013-07

10.  Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage.

Authors:  Fernando E García-Arroyo; Guillermo Gonzaga; Itzel Muñoz-Jiménez; Mónica G Blas-Marron; Octaviano Silverio; Edilia Tapia; Virgilia Soto; Natarajan Ranganathan; Pari Ranganathan; Usha Vyas; Anthony Irvin; Diana Ir; Charles E Robertson; Daniel N Frank; Richard J Johnson; L Gabriela Sánchez-Lozada
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.